By Victor Omondi Two widely used type 2 diabetes drugs are being recalled for allegedly containing traces of carcinogenic compounds. Metformin is meant to lower glucose levels. On Monday, Nostrum Laboratories Inc. in Kansas City, Missouri, announced that it’s voluntarily recalling its metformin HCl extended release tablets, USP 750 mg, based on a recall published […]
